Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 28, 2014; 20(36): 13159-13166
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.13159
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.13159
Table 2 Demographic and clinical characteristics of children according to donor hepatitis B core antibody status
Characteristic | HBcAb(+) donor(n = 16) | HBcAb(-) donor(n = 14) | P value |
Donors | |||
Gender (n, M/F) | 7/9 | 9/5 | 0.261 |
Age (yr) | 35 (20-55) | 32 (22-54) | 0.884 |
HBsAb (+/-) | 14/2 | 9/5 | 0.134 |
Recipients | |||
Age (mo) | 11 (7-43) | 12 (6-57) | 0.787 |
Gender (n, M/F) | 9/7 | 8/6 | 0.981 |
PELD score | 16 ± 3 | 17 ± 4 | 0.378 |
Preoperative HBcAb (n, +/-) | 11/5 | 5/9 | 0.070 |
Preoperative HBsAb (n, +/-) | 11/5 | 7/7 | 0.300 |
Preoperative HBsAb/HBcAb (n, +/-) | 9/7 | 3/11 | 0.052 |
Blood transfusion | |||
RBC (mL) | 502 ± 284 | 534 ± 224 | 0.379 |
FFP (mL) | 404 ± 177 | 424 ± 210 | 0.753 |
Dose of corticosteroid/body weight (mg/kg) | 44 ± 7 | 42 ± 8 | 0.359 |
Trough value of TAC | |||
First 3 mo (ng/mL) | 8.1 ± 5.6 | 7.8 ± 4.6 | 0.789 |
3 mo later (ng/mL) | 6.7 ± 3.2 | 6.4 ± 2.3 | 0.661 |
Follow-up (mo) | 15 (4-40) | 16 (14-30) | 0.228 |
De novo HBV infection (n, +/-) | 5/11 | 0/14 | 0.022 |
-
Citation: Rao W, Xie M, Yang T, Zhang JJ, Gao W, Deng YL, Zheng H, Pan C, Liu YH, Shen ZY. Risk factors for
de novo hepatitis B infection in pediatric living donor liver transplantation. World J Gastroenterol 2014; 20(36): 13159-13166 - URL: https://www.wjgnet.com/1007-9327/full/v20/i36/13159.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i36.13159